Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice
Bérengère Benoit, Emmanuelle Meugnier, Martina Castelli, et al.
Nature Medicine (2017) Vol. 23, Iss. 8, pp. 990-996
Open Access | Times Cited: 184

Showing 1-25 of 184 citing articles:

Mechanisms of muscle atrophy and hypertrophy: implications in health and disease
Roberta Sartori, Vanina Romanello, Marco Sandri
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 605
FGF/FGFR signaling in health and disease
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 598
Bile acids in glucose metabolism in health and disease
Hagit Shapiro, Aleksandra A. Kolodziejczyk, Daniel Halstuch, et al.
The Journal of Experimental Medicine (2018) Vol. 215, Iss. 2, pp. 383-396
Open Access | Times Cited: 363
Targeting the alternative bile acid synthetic pathway for metabolic diseases
Jia Wang, Meilin Wei, Cynthia Rajani, et al.
Protein & Cell (2020) Vol. 12, Iss. 5, pp. 411-425
Open Access | Times Cited: 232
Skeletal muscle atrophy: From mechanisms to treatments
Lin Yin, Na Li, Weihua Jia, et al.
Pharmacological Research (2021) Vol. 172, pp. 105807-105807
Closed Access | Times Cited: 226
Metabolic Messengers: FGF21
Kyle H. Flippo, Matthew J. Potthoff
Nature Metabolism (2021) Vol. 3, Iss. 3, pp. 309-317
Open Access | Times Cited: 204
Fibroblast growth factor 21 controls mitophagy and muscle mass
Lynette J. Oost, Monika Kustermann, Andrea Armani, et al.
Journal of Cachexia Sarcopenia and Muscle (2019) Vol. 10, Iss. 3, pp. 630-642
Open Access | Times Cited: 181
Impact of Gut Microbiota on Host Glycemic Control
Céline Gérard, Hubert Vidal
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 177
Signaling Pathways That Control Muscle Mass
Anna Vainshtein, Marco Sandri
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4759-4759
Open Access | Times Cited: 155
Bile Acids and FXR: Novel Targets for Liver Diseases
Mary Stofan, Grace L. Guo
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 154
FXR in liver physiology: Multiple faces to regulate liver metabolism
Katrin Panzitt, Martin Wagner
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1867, Iss. 7, pp. 166133-166133
Open Access | Times Cited: 112
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis
Takeshi Katafuchi, Makoto Makishima
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6046-6046
Open Access | Times Cited: 89
Gut microbiota–bile acid–skeletal muscle axis
Laura Mancin, Gary D. Wu, Antonio Paoli
Trends in Microbiology (2022) Vol. 31, Iss. 3, pp. 254-269
Open Access | Times Cited: 80
FGF-based drug discovery: advances and challenges
Gaozhi Chen, Lingfeng Chen, Xiaokun Li, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4
The FGF metabolic axis
Xiaokun Li
Frontiers of Medicine (2019) Vol. 13, Iss. 5, pp. 511-530
Open Access | Times Cited: 120
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
Christoffer Clemmensen, Brian Finan, Timo D. Müller, et al.
Nature Reviews Endocrinology (2018) Vol. 15, Iss. 2, pp. 90-104
Closed Access | Times Cited: 106
Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
Emmanuel Somm, François R. Jornayvaz
Endocrine Reviews (2018) Vol. 39, Iss. 6, pp. 960-989
Open Access | Times Cited: 94
Bone and Muscle Crosstalk in Aging
Chen He, Wenzhen He, Jing Hou, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 92
Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans
Thomas Morville, Ronni E. Sahl, Samuel A.J. Trammell, et al.
JCI Insight (2018) Vol. 3, Iss. 15
Open Access | Times Cited: 89
Metabolic aspects of muscle wasting during critical illness
Rob J. J. van Gassel, Michelle R. Baggerman, Marcel C.G. van de Poll
Current Opinion in Clinical Nutrition & Metabolic Care (2020) Vol. 23, Iss. 2, pp. 96-101
Open Access | Times Cited: 88
Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons Learned From Bariatric Surgery
Nadejda Bozadjieva-Kramer, Kristy M. Heppner, Randy J. Seeley
Diabetes (2018) Vol. 67, Iss. 9, pp. 1720-1728
Open Access | Times Cited: 86
Klotho: An Elephant in Aging Research
Amin Cheikhi, Aaron Barchowsky, Amrita Sahu, et al.
The Journals of Gerontology Series A (2019) Vol. 74, Iss. 7, pp. 1031-1042
Open Access | Times Cited: 80
FGF19 protects skeletal muscle against obesity‐induced muscle atrophy, metabolic derangement and abnormal irisin levels via the AMPK/SIRT‐1/PGC‐α pathway
Ai Guo, Kai Li, Hongchuan Tian, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 7, pp. 3585-3600
Open Access | Times Cited: 72
Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
Yixuan Qiu, Jiaming Yu, Yi Li, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 508-522
Open Access | Times Cited: 71
Page 1 - Next Page

Scroll to top